A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

NCT06972888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: AC-201
DRUG: Placebo

Sponsor

Accro Bioscience (Suzhou) Limited